Market Overview

Benzinga's Top Upgrades

Share:
Benzinga's Top Upgrades
Related ADTN
Benzinga's Top Downgrades
Goldman Sachs Downgrades ADTRAN To Neutral
Related MDT
4 Biomedical Stocks Canaccord Loves
Medtronic plc: Medtronic Drug-Coated Balloon for Treatment of Peripheral Arterial Disease Shows Strong Results in Long Lesions
Edwards Lifesciences Showcases The Problem With Quant Investing (Seeking Alpha)

Analysts at Citigroup upgraded ADTRAN (NASDAQ: ADTN) from “sell” to “neutral.” ADTRAN's stock closed at $21.96 yesterday. ADTRAN had $228.94 million in total cash for the latest quarter.

Credit Suisse upgraded Medtronic (NYSE: MDT) from “neutral” to “outperform.” Medtronic's shares closed at $43.94 yesterday. Medtronic's PEG ratio is 2.23.

Analysts at JP Morgan upgraded Juniper Networks (NYSE: JNPR) from “neutral” to “overweight.” Juniper's shares closed at $20.98 yesterday. Juniper's trailing-twelve-month revenue is $4.35 billion.

Macquarie upgraded Mercury General (NYSE: MCY) from “neutral” to “outperform.” Mercury General's shares closed at $39.17 yesterday. Mercury General's trailing-twelve-month operating margin is 10.10%.

Latest Ratings for ADTN

DateFirmActionFromTo
Apr 2015NeedhamDowngradesBuyHold
Apr 2015Goldman SachsDowngradesBuyNeutral
Apr 2015JP MorganMaintainsNeutral

View More Analyst Ratings for ADTN
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (ADTN + JNPR)

Around the Web, We're Loving...